Index -
P/E 28.66
EPS (ttm) 0.70
Insider Own 34.00%
Shs Outstand 1.62B
Perf Week -0.05%
Market Cap 36.08B
Forward P/E 36.73
EPS next Y 0.55
Insider Trans -7.35%
Shs Float 1.18B
Perf Month -5.17%
Income 1.27B
PEG 40.94
EPS next Q 0.01
Inst Own 54.98%
Short Float 1.99%
Perf Quarter -12.38%
Sales 25.70B
P/S 1.40
EPS this Y -87.73%
Inst Trans 0.00%
Short Ratio 2.89
Perf Half Y 38.98%
Book/sh 2.27
P/B 8.88
EPS next Y 496.79%
ROA 10.33%
Short Interest 23.51M
Perf Year 17.46%
Cash/sh 3.12
P/C 6.47
EPS next 5Y 0.70%
ROE 38.36%
52W Range 13.51 - 23.77
Perf YTD 24.64%
Dividend Est. -
P/FCF 25.14
EPS past 5Y -
ROI 18.70%
52W High -15.10%
Beta 1.10
Dividend TTM -
Quick Ratio 0.89
Sales past 5Y 45.92%
Gross Margin 26.07%
52W Low 49.37%
ATR (14) 0.58
Dividend Ex-Date -
Current Ratio 1.15
EPS Y/Y TTM 507.33%
Oper. Margin 1.58%
RSI (14) 40.58
Volatility 2.61% 2.55%
Employees 78000
Debt/Eq 0.89
Sales Y/Y TTM 20.83%
Profit Margin 4.96%
Recom 1.68
Target Price 26.14
Option/Short Yes / Yes
LT Debt/Eq 0.67
EPS Q/Q -94.66%
Payout 0.00%
Rel Volume 1.14
Prev Close 19.79
Sales Surprise 2.42%
EPS Surprise -100.00%
Sales Q/Q 22.64%
Earnings Aug 06 AMC
Avg Volume 8.13M
Price 20.18
SMA20 -3.63%
SMA50 -6.67%
SMA200 9.21%
Trades
Volume 9,251,479
Change 1.97%
Date
Action
Analyst
Rating Change
Price Target Change
May-16-24 Upgrade
UBS
Neutral → Buy
$26
May-03-24 Resumed
BofA Securities
Buy
$30
Apr-15-24 Upgrade
Citigroup
Neutral → Buy
$19 → $26
Feb-29-24 Upgrade
Deutsche Bank
Hold → Buy
$18.50 → $21
Jan-16-24 Downgrade
Citigroup
Buy → Neutral
$20 → $17
Dec-20-23 Downgrade
UBS
Buy → Neutral
$26 → $18.50
Aug-09-23 Downgrade
Deutsche Bank
Buy → Hold
$20
Mar-02-23 Downgrade
BofA Securities
Buy → Neutral
$27 → $18
Mar-01-23 Upgrade
Deutsche Bank
Hold → Buy
$20
Feb-09-23 Initiated
Barclays
Overweight
$20
Dec-01-22 Initiated
New Street
Buy
$25
Oct-07-22 Initiated
HSBC Securities
Buy
$27.80
Aug-16-22 Downgrade
CLSA
Outperform → Sell
$16.40
Aug-11-22 Downgrade
Deutsche Bank
Buy → Hold
$15 → $18.50
Aug-09-22 Initiated
Macquarie
Outperform
$26
Jul-01-22 Upgrade
Credit Suisse
Neutral → Outperform
$28 → $19
Jun-29-22 Initiated
Morgan Stanley
Overweight
$18
May-12-22 Upgrade
Citigroup
Neutral → Buy
$29 → $15
May-06-22 Upgrade
JP Morgan
Neutral → Overweight
$25 → $17
Mar-22-22 Upgrade
Deutsche Bank
Hold → Buy
Show Previous Ratings
Today 05:50PM
Jul-23-24 06:00PM
04:00PM
Jul-19-24 09:00AM
Jul-16-24 06:00PM
09:30AM
Loading…
Jul-12-24 09:30AM
Jul-11-24 10:00AM
09:00AM
Jul-09-24 06:00PM
Jul-08-24 04:15PM
12:51PM
09:01AM
Jul-04-24 04:01PM
Jun-29-24 10:02AM
08:25AM
06:00PM
Loading…
Jun-27-24 06:00PM
06:44AM
Jun-26-24 09:30AM
01:42AM
Jun-25-24 04:01PM
09:00AM
Jun-21-24 06:00PM
Jun-15-24 08:30AM
Jun-11-24 09:00AM
Jun-10-24 04:44AM
Jun-05-24 08:46AM
Jun-01-24 08:00AM
May-31-24 10:49AM
May-29-24 09:00AM
May-28-24 11:58AM
02:24AM
Loading…
02:24AM
May-26-24 07:13AM
07:00AM
May-23-24 06:15AM
May-22-24 09:10AM
09:00AM
May-17-24 09:49AM
09:30AM
May-16-24 09:20AM
07:05AM
May-15-24 09:20PM
01:55PM
02:22AM
May-11-24 02:43AM
May-10-24 01:04AM
May-09-24 11:11AM
May-08-24 02:23PM
(Investor's Business Daily) -9.26%
11:16AM
10:24AM
07:00AM
(Thomson Reuters StreetEvents)
May-07-24 09:15PM
09:01PM
07:55PM
06:24PM
05:43PM
05:35PM
04:12PM
04:10PM
04:00PM
May-06-24 08:05AM
03:12AM
May-05-24 03:02AM
May-04-24 08:15AM
May-03-24 05:15AM
May-02-24 05:45PM
06:15AM
May-01-24 10:00AM
Apr-30-24 10:01AM
Apr-28-24 09:45AM
Apr-26-24 05:45PM
Apr-24-24 02:17AM
Apr-23-24 04:00PM
Apr-21-24 08:45AM
Apr-18-24 04:33PM
09:09AM
Apr-17-24 01:12PM
08:00AM
Apr-15-24 01:58PM
10:36AM
Apr-12-24 08:39PM
04:35PM
(Investor's Business Daily)
02:05PM
01:35PM
12:02PM
Apr-11-24 10:00AM
Apr-03-24 06:00AM
Apr-02-24 04:00PM
Apr-01-24 07:21AM
Mar-31-24 04:25AM
Mar-29-24 09:45AM
Mar-28-24 10:30AM
Mar-22-24 03:25PM
Mar-19-24 09:13AM
Mar-16-24 06:00AM
Mar-15-24 11:04AM
Mar-11-24 06:00PM
Mar-08-24 09:40AM
Mar-07-24 02:59AM
Mar-06-24 01:01PM
06:54AM
(The Wall Street Journal)
Coupang, Inc. engages in operating an e-commerce platform. It operates through the following segments: Product Commerce and Developing Offerings segments. The Product Commerce segment provides core retail and marketplace offerings and Rocket Fresh, as well as advertising products associated with these offerings. The Developing Offerings segment includes nascent offerings and services, including Coupang Eats, Coupang Play, international and fintech initiatives. The company was founded in 2010 and is headquartered in Seattle, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kolari Pranam See Remarks Jul 02 '24 Sale 21.13 673 14,220 180,788 Jul 03 04:26 PM Sun Benjamin Director Jun 17 '24 Sale 20.63 700,000 14,441,000 2,169,421 Jun 17 08:33 PM Kang Hanseung Rep Director, Business Mngmt May 30 '24 Sale 23.00 40,000 920,000 544,478 May 31 04:56 PM Kolari Pranam See Remarks May 20 '24 Sale 22.93 6,490 148,816 181,461 May 21 04:47 PM GREENOAKS CAPITAL PARTNERS LLC Director May 14 '24 Buy 22.28 298,550 6,650,440 48,924,924 May 14 09:00 PM GREENOAKS CAPITAL PARTNERS LLC Director May 13 '24 Buy 22.06 500,000 11,029,950 48,626,374 May 14 09:00 PM GREENOAKS CAPITAL PARTNERS LLC Director May 10 '24 Buy 22.53 120,239 2,709,057 48,126,374 May 14 09:00 PM Lee Jonathan D. Chief Accounting Officer May 09 '24 Sale 21.45 5,000 107,250 120,835 May 10 04:38 PM Kolari Pranam See Remarks May 02 '24 Sale 22.34 2,048 45,752 187,951 May 03 04:48 PM Rogers Harold See Remarks Mar 18 '24 Sale 18.25 139,080 2,538,210 394,192 Mar 19 05:21 PM MEHTA NEIL Director Mar 14 '24 Sale 18.68 1,600,000 29,894,831 48,006,135 Mar 18 09:32 PM SVF Investments (UK) Ltd 10% Owner Mar 13 '24 Sale 19.60 15,000,000 294,000,000 349,542,259 Mar 14 09:00 PM SVF Investments (UK) Ltd 10% Owner Mar 12 '24 Sale 19.01 31,614,154 600,927,187 364,542,259 Mar 14 09:00 PM Kang Hanseung Rep Director, Business Mngmt Mar 12 '24 Sale 19.25 48,000 924,000 519,987 Mar 13 04:48 PM Kolari Pranam See Remarks Feb 02 '24 Sale 13.88 2,356 32,701 182,844 Feb 06 06:09 PM Kim Tae Jung See Remarks Jan 02 '24 Sale 16.00 5,350 85,600 248,240 Jan 03 05:56 PM Kim Tae Jung See Remarks Dec 04 '23 Sale 15.50 940 14,570 253,590 Dec 05 06:52 PM SVF Investments (UK) Ltd 10% Owner Nov 29 '23 Sale 15.39 30,000,000 461,700,000 396,156,413 Dec 01 09:00 PM Kim Tae Jung See Remarks Oct 02 '23 Sale 16.95 4,673 79,207 254,530 Oct 03 07:02 PM Kim Tae Jung See Remarks Sep 05 '23 Sale 18.99 939 17,832 259,203 Sep 06 05:17 PM
Index -
P/E 2.13
EPS (ttm) 5.07
Insider Own 33.89%
Shs Outstand 806.68M
Perf Week -1.82%
Market Cap 7.98B
Forward P/E -
EPS next Y -1.12
Insider Trans -0.04%
Shs Float 488.34M
Perf Month 2.18%
Income 4.35B
PEG -
EPS next Q -0.24
Inst Own 60.21%
Short Float 8.37%
Perf Quarter -0.74%
Sales 124.80M
P/S 63.93
EPS this Y -119.86%
Inst Trans 2.84%
Short Ratio 8.37
Perf Half Y 2.66%
Book/sh 7.40
P/B 1.46
EPS next Y -8.00%
ROA 90.49%
Short Interest 40.85M
Perf Year -1.19%
Cash/sh 8.85
P/C 1.22
EPS next 5Y -
ROE 122.05%
52W Range 8.24 - 13.24
Perf YTD -3.83%
Dividend Est. -
P/FCF -
EPS past 5Y 0.08%
ROI 67.46%
52W High -18.43%
Beta 1.24
Dividend TTM -
Quick Ratio 25.10
Sales past 5Y 493.24%
Gross Margin 74.95%
52W Low 30.99%
ATR (14) 0.29
Dividend Ex-Date -
Current Ratio 25.24
EPS Y/Y TTM 476.90%
Oper. Margin -865.37%
RSI (14) 45.94
Volatility 2.19% 2.63%
Employees 908
Debt/Eq 0.08
Sales Y/Y TTM 103.65%
Profit Margin 3484.86%
Recom 1.17
Target Price 17.00
Option/Short Yes / Yes
LT Debt/Eq 0.08
EPS Q/Q -315.45%
Payout 0.00%
Rel Volume 0.73
Prev Close 10.74
Sales Surprise -6.70%
EPS Surprise 28.14%
Sales Q/Q 5.68%
Earnings May 30 BMO
Avg Volume 4.88M
Price 10.80
SMA20 -1.44%
SMA50 -0.94%
SMA200 2.47%
Trades
Volume 3,577,314
Change 0.56%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-15-24 Initiated
Wolfe Research
Outperform
$17
Jan-05-24 Initiated
Piper Sandler
Overweight
$20
Dec-12-23 Initiated
Deutsche Bank
Buy
$14
Oct-17-23 Initiated
Guggenheim
Buy
$17
Jun-08-23 Initiated
BofA Securities
Neutral
$10.50
Oct-27-22 Initiated
JP Morgan
Overweight
$7
May-23-22 Initiated
SVB Leerink
Outperform
$6
Apr-29-22 Initiated
Cantor Fitzgerald
Overweight
$15
Dec-15-21 Initiated
Goldman
Buy
$15
Nov-08-21 Initiated
H.C. Wainwright
Buy
$14
Oct-28-21 Initiated
Citigroup
Buy
$11
Oct-26-21 Initiated
Truist
Buy
$15
Oct-26-21 Initiated
Jefferies
Buy
$10
Oct-26-21 Initiated
Cowen
Outperform
Show Previous Ratings
Jul-25-24 04:05PM
May-31-24 08:04AM
May-30-24 11:53AM
08:20AM
07:00AM
06:28PM
Loading…
May-27-24 06:28PM
06:13PM
May-16-24 04:05PM
May-08-24 02:43AM
May-07-24 02:04PM
May-01-24 10:47AM
Apr-25-24 08:00AM
Apr-12-24 11:09AM
Apr-02-24 07:00AM
Mar-27-24 01:55PM
(The Wall Street Journal) +7.54%
06:22PM
Loading…
Mar-26-24 06:22PM
Mar-17-24 08:50AM
Mar-14-24 07:04AM
Feb-15-24 02:45AM
Feb-13-24 07:00AM
Feb-10-24 02:55AM
Jan-30-24 04:05PM
Dec-27-23 08:05PM
Dec-20-23 04:30PM
(GlobeNewswire) -7.78%
+5.82%
Dec-14-23 09:00AM
Nov-28-23 07:00AM
02:38AM
Nov-27-23 08:00AM
Nov-14-23 01:00PM
Nov-13-23 07:00AM
08:00AM
Loading…
Nov-10-23 08:00AM
Oct-30-23 05:30PM
Oct-24-23 08:00AM
(The Wall Street Journal)
Oct-23-23 03:02PM
10:31AM
09:52AM
06:55AM
(The Wall Street Journal)
03:49AM
(The Wall Street Journal)
01:00AM
Oct-13-23 08:00AM
Oct-05-23 05:01AM
Oct-03-23 07:00AM
(The Wall Street Journal)
Sep-30-23 05:00AM
Sep-26-23 06:00AM
Sep-11-23 08:00AM
Sep-09-23 10:51AM
(The Wall Street Journal)
Aug-17-23 04:05PM
Aug-14-23 07:00AM
Aug-03-23 04:05PM
Aug-02-23 04:05PM
Jul-27-23 08:00AM
Jul-26-23 10:21AM
Jul-13-23 05:50PM
(The Wall Street Journal)
Jul-11-23 08:00AM
Jun-28-23 08:57AM
07:00AM
Jun-26-23 04:05PM
Jun-22-23 07:30AM
Jun-21-23 05:00PM
May-16-23 07:00AM
Apr-04-23 07:37AM
07:37AM
Mar-28-23 08:00AM
Mar-15-23 07:45AM
Mar-14-23 04:07PM
08:00AM
Mar-07-23 08:00AM
Feb-21-23 08:32PM
Feb-13-23 04:17PM
(The Wall Street Journal)
+7.77%
07:00AM
Feb-02-23 09:14PM
Feb-01-23 04:05PM
Jan-30-23 08:00AM
Jan-04-23 06:05AM
Dec-07-22 06:30AM
Dec-01-22 08:00AM
Nov-14-22 07:00AM
Nov-10-22 09:00AM
Nov-08-22 06:15AM
Nov-07-22 04:01PM
Oct-18-22 04:00PM
Aug-30-22 07:00AM
Aug-16-22 11:44AM
Aug-15-22 07:00AM
Aug-14-22 10:53AM
Aug-03-22 07:00AM
Jul-23-22 09:00AM
Jun-30-22 09:18AM
Jun-28-22 06:27AM
06:10AM
06:00AM
Jun-15-22 04:30PM
(GlobeNewswire) +7.90%
-5.21%
May-24-22 06:00AM
May-19-22 04:30PM
May-16-22 07:00AM
May-09-22 11:16AM
(Simply Wall St.) -12.71%
May-02-22 07:00AM
Apr-20-22 07:00AM
Apr-13-22 07:00AM
Mar-25-22 08:01AM
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Venker Eric President & COO Feb 09 '24 Option Exercise 3.85 96,950 373,258 629,157 Feb 09 09:00 PM Venker Eric President & COO Feb 09 '24 Sale 10.92 96,950 1,058,694 532,207 Feb 09 09:00 PM Ramaswamy Vivek 10% Owner Jan 02 '24 Sale 11.05 3,000,000 33,150,000 51,929,426 Jan 03 04:56 PM Venker Eric Chief Operating Officer Oct 05 '23 Sale 10.11 153,027 1,547,103 595,397 Oct 04 09:30 PM Venker Eric Chief Operating Officer Oct 04 '23 Option Exercise 3.85 153,027 589,154 748,424 Oct 04 09:30 PM Venker Eric Chief Operating Officer Oct 03 '23 Option Exercise 3.85 606,221 2,333,951 1,201,618 Oct 04 09:30 PM Venker Eric Chief Operating Officer Oct 03 '23 Sale 10.25 606,221 6,213,765 595,397 Oct 04 09:30 PM Venker Eric Chief Operating Officer Oct 02 '23 Option Exercise 3.85 440,752 1,696,895 1,036,149 Oct 04 09:30 PM Roivant Sciences Ltd. Director Oct 02 '23 Buy 38.00 1,526,316 58,000,008 79,805,331 Oct 04 05:15 PM Venker Eric Chief Operating Officer Oct 02 '23 Sale 10.80 440,752 4,760,122 595,397 Oct 04 09:30 PM SVF Investments (UK) Ltd 10% Owner Sep 28 '23 Sale 12.60 10,000,000 126,000,000 73,031,667 Oct 02 09:00 PM Gold Daniel Allen Director Sep 28 '23 Sale 11.55 10,000,000 115,500,000 100,804 Oct 02 08:55 PM QVT Financial LP Director by Deputization Sep 28 '23 Sale 11.55 10,000,000 115,500,000 100,804 Oct 02 08:43 PM MANCHESTER KEITH S Director Sep 28 '23 Sale 11.55 6,896,144 79,650,463 5,023,787 Oct 02 09:05 PM Venker Eric President & COO Sep 27 '23 Option Exercise 3.85 500,000 1,925,000 1,095,397 Sep 29 09:30 PM Venker Eric President & COO Sep 27 '23 Sale 13.02 500,000 6,510,000 595,397 Sep 29 09:30 PM Kumar Rakhi Chief Accounting Officer Sep 08 '23 Option Exercise 6.48 99,350 643,788 297,300 Sep 12 09:30 PM Venker Eric Chief Operating Officer Sep 08 '23 Option Exercise 3.85 106,430 409,756 718,243 Sep 12 09:32 PM Venker Eric Chief Operating Officer Sep 08 '23 Sale 12.19 106,430 1,297,382 611,813 Sep 12 09:32 PM Kumar Rakhi Chief Accounting Officer Sep 08 '23 Sale 12.18 99,350 1,210,083 197,950 Sep 12 09:30 PM Venker Eric Chief Operating Officer Sep 06 '23 Option Exercise 3.85 5,926 22,815 617,739 Sep 06 09:30 PM Venker Eric Chief Operating Officer Sep 06 '23 Sale 11.85 5,926 70,223 611,813 Sep 06 09:30 PM Venker Eric Chief Operating Officer Sep 05 '23 Option Exercise 3.85 73,275 282,109 685,088 Sep 06 09:30 PM Kumar Rakhi Chief Accounting Officer Sep 05 '23 Option Exercise 6.48 1,724 11,172 199,674 Sep 07 09:30 PM Venker Eric Chief Operating Officer Sep 05 '23 Sale 11.92 73,275 873,438 611,813 Sep 06 09:30 PM Kumar Rakhi Chief Accounting Officer Sep 05 '23 Sale 12.00 1,724 20,688 197,950 Sep 07 09:30 PM Venker Eric Chief Operating Officer Sep 01 '23 Option Exercise 3.85 14,763 56,838 626,576 Sep 06 09:30 PM Venker Eric Chief Operating Officer Sep 01 '23 Sale 11.90 14,763 175,680 611,813 Sep 06 09:30 PM Venker Eric Chief Operating Officer Aug 14 '23 Option Exercise 3.85 59,811 230,272 687,729 Aug 16 09:34 PM Venker Eric Chief Operating Officer Aug 14 '23 Sale 11.89 59,811 711,153 627,918 Aug 16 09:34 PM Venker Eric Chief Operating Officer Aug 03 '23 Option Exercise 3.85 44,629 171,822 672,547 Aug 07 09:30 PM Kumar Rakhi Chief Accounting Officer Aug 03 '23 Option Exercise 6.48 3,681 23,853 203,009 Aug 03 09:30 PM Venker Eric Chief Operating Officer Aug 03 '23 Sale 11.93 44,629 532,424 627,918 Aug 07 09:30 PM Kumar Rakhi Chief Accounting Officer Aug 03 '23 Sale 12.00 3,681 44,172 199,328 Aug 03 09:30 PM Venker Eric Chief Operating Officer Aug 02 '23 Option Exercise 3.85 16,397 63,128 644,315 Aug 02 09:30 PM Venker Eric Chief Operating Officer Aug 02 '23 Sale 11.86 16,397 194,468 627,918 Aug 02 09:30 PM Venker Eric Chief Operating Officer Aug 01 '23 Option Exercise 3.85 61,397 236,378 689,315 Aug 02 09:30 PM Kumar Rakhi Chief Accounting Officer Aug 01 '23 Option Exercise 6.48 336 2,177 199,664 Aug 03 09:30 PM Venker Eric Chief Operating Officer Aug 01 '23 Sale 11.92 61,397 731,852 627,918 Aug 02 09:30 PM Kumar Rakhi Chief Accounting Officer Aug 01 '23 Sale 12.00 336 4,032 199,328 Aug 03 09:30 PM Venker Eric Chief Operating Officer Jul 31 '23 Option Exercise 3.85 117,372 451,882 745,290 Aug 02 09:30 PM Venker Eric Chief Operating Officer Jul 31 '23 Sale 11.91 117,372 1,397,901 627,918 Aug 02 09:30 PM Venker Eric Chief Operating Officer Jul 27 '23 Option Exercise 3.85 23,622 90,945 651,540 Jul 27 09:30 PM Venker Eric Chief Operating Officer Jul 27 '23 Sale 10.98 23,622 259,370 627,918 Jul 27 09:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite